相似文献
1
Challenges of community point-of-care antibody testing for COVID-19 herd-immunity in Japan.日本针对新冠病毒群体免疫开展社区即时抗体检测的挑战。
QJM. 2020 Nov 1;113(11):785-786. doi: 10.1093/qjmed/hcaa182.
2
The COVID-19 Pandemic in the US: A Clinical Update.美国的新冠疫情：临床最新情况
JAMA. 2020 May 12;323(18):1767-1768. doi: 10.1001/jama.2020.5788.
3
The explosion of new coronavirus tests that could help to end the pandemic.新型冠状病毒检测的激增可能有助于终结这场大流行。
Nature. 2020 Jul;583(7817):506-509. doi: 10.1038/d41586-020-02140-8.
4
Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.群体免疫——评估受影响国家遏制新冠疫情所需的群体免疫水平。
J Infect. 2020 Jun;80(6):e32-e33. doi: 10.1016/j.jinf.2020.03.027. Epub 2020 Mar 21.
5
Will antibody tests for the coronavirus really change everything?新冠病毒抗体检测真的会改变一切吗？
Nature. 2020 Apr;580(7805):571-572. doi: 10.1038/d41586-020-01115-z.
6
New, At-Home Antibody Test for Detecting, Tracking COVID-19.用于检测和追踪新冠病毒的新型家用抗体检测
IEEE Pulse. 2020 Sep-Oct;11(5):28-31. doi: 10.1109/MPULS.2020.3022203.
7
A Simple Algorithm for Return to Workplace Employer Antibody Testing.一种用于返回工作场所雇主抗体检测的简单算法。
Popul Health Manag. 2020 Oct;23(5):346-349. doi: 10.1089/pop.2020.0136. Epub 2020 Aug 26.
8
Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.SARS-CoV-2 血清学检测：关注、机遇与未来方向。
Sci Immunol. 2020 May 19;5(47). doi: 10.1126/sciimmunol.abc6347.
9
Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS-CoV-2/COVID-19.美国微生物学会2020年3月23日新型冠状病毒肺炎国际峰会报告：严重急性呼吸综合征冠状病毒2型/新型冠状病毒肺炎诊断检测的价值
mBio. 2020 Mar 26;11(2):e00722-20. doi: 10.1128/mBio.00722-20.
10
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Jun 3;16(696):1174-1175.
引用本文的文献
1
Optimizing national border reopening policies in the COVID-19 pandemic: A modeling study.优化 COVID-19 大流行期间的国家边境重新开放政策：建模研究。
Front Public Health. 2022 Nov 30;10:979156. doi: 10.3389/fpubh.2022.979156. eCollection 2022.
2
Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a nonepidemic region, Japan: A hospital-based study on May, 2020.2020 年 5 月，日本非流行地区医疗机构工作人员中 SARS-CoV-2 抗体的血清流行率：一项基于医院的研究。
J Med Virol. 2021 Jul;93(7):4608-4611. doi: 10.1002/jmv.26962. Epub 2021 Apr 3.
3
Orthogonal antibody testing for COVID-19 among healthcare workers in a non-epidemic place and time:Japan's Iwate Prefecture, May 18-31, 2020.2020 年 5 月 18 日至 31 日，非流行时期和地点的医护人员中的 COVID-19 正交抗体检测：日本岩手县。
Fukushima J Med Sci. 2021 Apr 10;67(1):27-32. doi: 10.5387/fms.2020-21. Epub 2021 Feb 26.
4
Measuring the Serologic Response to Severe Acute Respiratory Syndrome Coronavirus 2: Methods and Meaning.测量对严重急性呼吸综合征冠状病毒2的血清学反应：方法及意义
Clin Lab Med. 2020 Dec;40(4):603-614. doi: 10.1016/j.cll.2020.08.014. Epub 2020 Aug 8.
5
Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan.日本使用市售即时检测和实验室诊断方法对新冠疫情前样本进行的新型冠状病毒2型血清学检测
Diseases. 2020 Sep 23;8(4):36. doi: 10.3390/diseases8040036.
6
Geographical Profiles of COVID-19 Outbreak in Tokyo: An Analysis of the Primary Care Clinic-Based Point-of-Care Antibody Testing.东京新冠肺炎疫情的地理概况：基于基层医疗诊所即时检验抗体检测的分析
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720942695. doi: 10.1177/2150132720942695.
7
Underestimation of COVID-19 cases in Japan: an analysis of RT-PCR testing for COVID-19 among 47 prefectures in Japan.日本新冠肺炎病例低估：对日本 47 个都道府县进行的新冠肺炎 RT-PCR 检测分析。
QJM. 2020 Aug 1;113(8):551-555. doi: 10.1093/qjmed/hcaa209.
Zotero 插件